DE602005024036D1 - Umkehr-mizellen-zusammensetzung zur abgabe von metallkationen mit einem diglycerid und einem phytosterol und herstellungsverfahren - Google Patents

Umkehr-mizellen-zusammensetzung zur abgabe von metallkationen mit einem diglycerid und einem phytosterol und herstellungsverfahren

Info

Publication number
DE602005024036D1
DE602005024036D1 DE602005024036T DE602005024036T DE602005024036D1 DE 602005024036 D1 DE602005024036 D1 DE 602005024036D1 DE 602005024036 T DE602005024036 T DE 602005024036T DE 602005024036 T DE602005024036 T DE 602005024036T DE 602005024036 D1 DE602005024036 D1 DE 602005024036D1
Authority
DE
Germany
Prior art keywords
reverse
phytosterol
diglyceride
micro
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602005024036T
Other languages
German (de)
English (en)
Inventor
Jean-Claude Maurel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medesis Pharma SA
Original Assignee
Medesis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medesis Pharma SA filed Critical Medesis Pharma SA
Publication of DE602005024036D1 publication Critical patent/DE602005024036D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Polymers & Plastics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Transplantation (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Psychology (AREA)
DE602005024036T 2004-11-02 2005-11-02 Umkehr-mizellen-zusammensetzung zur abgabe von metallkationen mit einem diglycerid und einem phytosterol und herstellungsverfahren Expired - Lifetime DE602005024036D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04025987A EP1652512A1 (en) 2004-11-02 2004-11-02 Reverse micelle composition for delivery of metal cations comprising a diglyceride and a phytosterol and method of preparation
PCT/IB2005/003605 WO2006048773A1 (en) 2004-11-02 2005-11-02 Reverse micelle composition for delivery of metal cations comprising a diglyceride and a phytosterol and method of preparation

Publications (1)

Publication Number Publication Date
DE602005024036D1 true DE602005024036D1 (de) 2010-11-18

Family

ID=34927200

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005024036T Expired - Lifetime DE602005024036D1 (de) 2004-11-02 2005-11-02 Umkehr-mizellen-zusammensetzung zur abgabe von metallkationen mit einem diglycerid und einem phytosterol und herstellungsverfahren

Country Status (16)

Country Link
US (1) US9173838B2 (https=)
EP (2) EP1652512A1 (https=)
JP (1) JP4975631B2 (https=)
CN (1) CN101102751B (https=)
AT (1) ATE483454T1 (https=)
AU (1) AU2005300253B2 (https=)
CA (1) CA2584684C (https=)
DE (1) DE602005024036D1 (https=)
DK (1) DK1807048T3 (https=)
EA (1) EA012210B1 (https=)
ES (1) ES2353804T3 (https=)
IL (1) IL182756A (https=)
PL (1) PL1807048T3 (https=)
PT (1) PT1807048E (https=)
WO (1) WO2006048773A1 (https=)
ZA (1) ZA200704286B (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1652513A1 (en) * 2004-11-02 2006-05-03 Denderah Pharm Sa Reverse micelles based on sterols and acylglycerols and therapeutic uses thereof
CA2792136C (en) 2010-03-24 2020-08-04 Medesis Pharma Reverse micelle system comprising metal ions and use thereof
BRPI1000970A2 (pt) * 2010-04-07 2011-11-29 Fundacao Arnaldo Vieira De Carvalho composição farmacêutica para o tratamento da doença de alzheimer, processo para sua obtenção e uso
WO2012007387A1 (en) * 2010-07-13 2012-01-19 Medesis Pharma Low- dose lithium for the treatment of neurodegenerative disorders
WO2017005899A1 (en) * 2015-07-09 2017-01-12 Medesis Pharma In situ preparation of cyano-bridged metal nanop articles within a biocompatible reverse micellar system
CN112672735A (zh) * 2018-07-06 2021-04-16 麦迪西斯医药公司 对由辐射暴露引起的损伤的治疗和预防
WO2024184369A1 (en) * 2023-03-06 2024-09-12 Medesis Pharma Formulation for the buccal administration of a biocompatible reverse micelle system

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252333A (en) * 1987-04-27 1993-10-12 Scotia Holdings Plc Lithium salt-containing pharmaceutical compositions
FR2658816A1 (fr) * 1990-02-27 1991-08-30 Adir Nouveaux sels de metaux alcalinoterreux d'oxa-polyacides leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2729957B1 (fr) * 1995-01-31 1997-12-05 Maurel Sante Complexes organometalliques a base de sitosterols et d'acylglycerols et compositions pharmaceutiques et produits dietetiques en contenant.
FR2750606B1 (fr) * 1996-07-03 1999-01-29 Maurel Sante Complexes organometalliques a base de sitosterols et de diglycerides et compositions pharmaceutiques en contenant
JPH119988A (ja) * 1997-06-26 1999-01-19 Advanced Sukin Res Kenkyusho:Kk 油中水型マイクロエマルション
JPH1129464A (ja) * 1997-07-07 1999-02-02 Advanced Sukin Res Kenkyusho:Kk コレステロールを添加する油中水型マイクロエマルション
WO2000057721A2 (en) * 1999-03-26 2000-10-05 Akesis Pharmaceuticals, Inc. Edible solids for treatment of glucose metabolism disorders
US6623765B1 (en) * 2000-08-01 2003-09-23 University Of Florida, Research Foundation, Incorporated Microemulsion and micelle systems for solubilizing drugs
US6365176B1 (en) * 2000-08-08 2002-04-02 Functional Foods, Inc. Nutritional supplement for patients with type 2 diabetes mellitus for lipodystrophy
AU2002231724B2 (en) * 2001-01-25 2005-10-20 Unilever Plc Microemulsions
US20030113366A1 (en) * 2001-12-14 2003-06-19 Macgregor Alexander Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
EP1452175A1 (en) * 2003-02-28 2004-09-01 Medesis Pharma S.A. Manganese based organometallic complexes, pharmaceutical compositions and dietetic products
CN1457773A (zh) * 2003-06-02 2003-11-26 乐益 治疗糖尿病的双胍钒络合物颗粒剂和/或胶囊剂及其用途
EP1652513A1 (en) * 2004-11-02 2006-05-03 Denderah Pharm Sa Reverse micelles based on sterols and acylglycerols and therapeutic uses thereof

Also Published As

Publication number Publication date
WO2006048773A1 (en) 2006-05-11
EA012210B1 (ru) 2009-08-28
HK1108368A1 (en) 2008-05-09
ES2353804T3 (es) 2011-03-07
AU2005300253A1 (en) 2006-05-11
EP1807048B1 (en) 2010-10-06
IL182756A (en) 2011-02-28
ATE483454T1 (de) 2010-10-15
IL182756A0 (en) 2007-07-24
PL1807048T3 (pl) 2011-03-31
JP2008519026A (ja) 2008-06-05
ZA200704286B (en) 2008-09-25
EP1807048A1 (en) 2007-07-18
JP4975631B2 (ja) 2012-07-11
CN101102751A (zh) 2008-01-09
US9173838B2 (en) 2015-11-03
CN101102751B (zh) 2011-08-24
CA2584684A1 (en) 2006-05-11
AU2005300253B2 (en) 2010-09-09
PT1807048E (pt) 2010-11-29
CA2584684C (en) 2013-07-02
EA200700994A1 (ru) 2007-10-26
EP1652512A1 (en) 2006-05-03
US20090087477A1 (en) 2009-04-02
DK1807048T3 (da) 2011-01-10

Similar Documents

Publication Publication Date Title
DE60216108D1 (de) Vorrichtung zur herstellung von verbundstrukturen und verfahren zu deren herstellung
ATE511833T1 (de) Nanopartikel aus protein mit gekoppeltem apolipoprotein e zur überwindung der blut-hirn- schranke und verfahren zu ihrer herstellung
DE602004010296D1 (de) Pulver zur herstellung von edelmetallprodukten durch freiformherstellung und produkte
DE60203884D1 (de) Verfahren und elektrolysezelle zur herstellung von metall
WO2006093972A3 (en) Particles
DE60212827D1 (de) Verfahren und vorrichtung zur herstellung von laminierten verbundwerkstoffen
EP1263468A4 (en) SOLUBILIZING FORMULATION OF INSOLUBLE AGENTS IN WATER, AND PROCESS FOR PREPARING THE SAME
DE60324213D1 (de) Vorrichtung und Methode zur Produktion von elektrisch deionisiertem Wasser
ATE482966T1 (de) Verfahren zur herstellung von 7-alpha-alkylierte 19-norsteroide
ZA200704286B (en) Reverse micelle composition for delivery of metal cations comprising a diglyceride and a phytosterol and method of preparation
EP1727554A4 (en) METHODS OF TREATING PSYCHIATRIC DISORDERS, ALCOHOL AND DRUG ABUSE DISORDERS, AND OTHER DISORDERS USING COMBINATIONS CONTAINING OMEGA 3 FATTY ACIDS
ATE362707T1 (de) Verfahren zur herstellung von milchpulver und konzentrierten milchprodukten
DE60235596D1 (de) Grossflächenschablone mit Mikrostrukturen zur Herstellung von dicht gepackten Anordnungen
DE50305216D1 (de) Vorrichtung und verfahren zur kontinuierlichen herstellung von emulsionen oder dispersionen
ATE508776T1 (de) Elemente zur trennung von substanzen durch verteilung zwischen einer stationären und einer mobilen phase und verfahren zur herstellung einer trennvorrichtung
DE60143274D1 (de) Salzbadnitrierungsverfahren zur herstellung von eisenelementen mit verbesserter korrosionsbeständigkeit und eisenteile
DE602004014805D1 (de) Verfahren zur herstellung von pharmazeutischen multiteilchenförmigen produkten
DE112005003550A5 (de) Flüssige Bio-Brennstoffmischung sowie Verfahren und Vorrichtung zur Herstellung derselben
ATE458743T1 (de) Zwischenprodukt und verfahren zur herstellung von an beta-anomeren angereicherten 2'-desoxy,2',2'- difluor-d-ribufuranosylnukleosiden
EP1905900A3 (de) Brücke mit zwei fachwerkartig ausgebildeten Scheiben und Bausatz zu deren Herstellung
DE60321751D1 (de) Polyurethan-Harnstoffe, nützlich zur Herstellung von Spandex und ein Verfahren zu ihrer Herstellung
DE50304803D1 (de) Verfahren zur instandsetzung und fertigung von geometrisch komplexen bauteilen
DE60217170D1 (de) Verfahren und vorrichtung zur herstellung gewellter verbundplatten
DE60210184D1 (de) L-cystein herstellendes Bakterium und Verfahren zur Herstellung von L-cystein
DE60329952D1 (de) Polyurethan-Harnstoffe, nützlich zur Herstellung von Spandex und ein Verfahren zu ihrer Herstellung